MedPath

Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain

Phase 1
Conditions
TMD
Interventions
Radiation: low level laser therapy
Registration Number
NCT01659372
Lead Sponsor
Shahid Beheshti University
Brief Summary

tempromandibuar disorders are a group of heterogenous pathologies affecting temporomandibular joint,muscles or both.in more than 90%of cases muscles are the origin of pain.TMDs cause pain,movement disability and deficit in quality of life.in more than 90%of cases pain is the major complaint.we run this investigation to find the analgesic effct of low level laser therapy versus pharmacotherapy with naproxen in improving pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients with TMD affecting masticatory muscles
Exclusion Criteria
  • systemic disease
  • GI problem
  • pregnancy
  • epidermal cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
naproxenNaproxenthis arm takes naproxen 500 mg twice daily for 3weeks
Low level laser therapylow level laser therapythis arm recieves low level laser therapy treatment for 12 sessions.
Primary Outcome Measures
NameTimeMethod
reduction of paim measured by VAS1 month

VAS is visual analogue scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shahid Beheshti University

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath